Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (opens new window)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Avots‎: Intensive Care Med 2013;39(11):2011-9.

Raksts indeksēts‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (opens new window)

Pediatric red blood cell transfusions increase resource use. (opens new window)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Avots‎: J Pediatr 2003;142(2):123-7.

Raksts indeksēts‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (opens new window)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (opens new window)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Avots‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Raksts indeksēts‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (opens new window)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (opens new window)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Avots‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Raksts indeksēts‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (opens new window)

Economic evaluation of cell salvage in pediatric surgery. (opens new window)

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

Avots‎: Paediatr Anaesth 2013;23(11):1027-34.

Raksts indeksēts‎: PubMed 23952976

DOI‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 (opens new window)